UBS Maintains Neutral on CryoPort, Raises Price Target to $9
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Dan Leonard maintains a Neutral rating on CryoPort (NASDAQ:CYRX) and raises the price target from $7 to $9.

October 18, 2024 | 1:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Dan Leonard maintains a Neutral rating on CryoPort but raises the price target from $7 to $9, indicating a positive outlook.
The increase in the price target from $7 to $9 suggests a more optimistic view on CryoPort's future performance, which could positively influence investor sentiment and potentially lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100